← Stomach Acid

Low Stomach Acid and Betaine HCl

What happens when stomach acid is too low, how it impairs digestion and nutrient absorption, and the evidence for betaine HCl supplementation as a natural remedy

Stomach acid — hydrochloric acid (HCl) — is far more than a digestive curiosity. It activates enzymes, sterilizes incoming food, and unlocks key nutrients like iron, B12, zinc, and protein. When acid output is too low — a condition called hypochlorhydria — digestion becomes incomplete, the small intestine becomes vulnerable to bacterial overgrowth, and deficiencies accumulate quietly over months or years [3]. The paradox is that many people diagnosed with acid reflux actually have too little stomach acid, not too much — and the acid-suppressing medications commonly prescribed can worsen the underlying problem [2]. Betaine HCl is a supplement that temporarily acidifies the stomach, providing targeted support for people with functionally low acid output.

What Stomach Acid Does

The stomach is designed to be intensely acidic — a healthy, fasting gastric pH typically sits between 1.5 and 3.5. This acidity performs several essential jobs:

Protein digestion. HCl activates pepsinogen, the inactive precursor of pepsin, converting it into the protease that begins breaking down dietary protein. Without adequate acid, proteins arrive partially intact in the small intestine, where they feed dysbiotic bacteria, trigger immune reactions, and reduce available amino acids for neurotransmitter synthesis — tryptophan, tyrosine, and phenylalanine are particularly affected [3].

Mineral liberation. Non-heme iron (from plant foods), calcium, magnesium, and zinc all require an acidic environment for absorption. Iron in particular depends on stomach acid to convert it from the ferric (Fe3+) to the more absorbable ferrous (Fe2+) form, and to release it from food-bound complexes [4].

Vitamin B12 absorption. Dietary B12 is bound to protein and must be cleaved by pepsin before it can attach to intrinsic factor for eventual absorption. Low acid impairs this cleavage, which is why long-term use of proton pump inhibitors (PPIs) is associated with B12 deficiency, and why food-bound B12 (from meals) is absorbed poorly after gastric bypass surgery — even though crystalline supplemental B12 remains unaffected [3].

Pathogen defense. Most bacteria and parasites ingested with food cannot survive gastric pH below 4. When acid is low, pathogens pass through more readily and can colonize the small intestine — a major contributor to SIBO (small intestinal bacterial overgrowth) and duodenal dysbiosis [5].

Causes of Low Stomach Acid

Helicobacter pylori infection is the most common correctable cause. H. pylori colonizes the gastric mucosa and over time causes chronic atrophic gastritis — progressive thinning and damage to acid-secreting parietal cells. In the early stages of infection, acid output may actually increase, promoting duodenal ulcers; in chronic infection affecting the body of the stomach, acid output falls progressively. Eradication of H. pylori can partially restore acid secretion [6].

Age-related decline. Gastric acid output decreases with age as parietal cell mass naturally diminishes. Estimates suggest that 30–40% of adults over 60 have some degree of atrophic gastritis, compared to under 5% in younger adults [3]. The delay in re-acidification after meals — documented as exceeding four hours in elderly individuals versus near-immediate recovery in younger subjects — means elderly people spend longer periods with an inadequately acidic stomach [2].

Acid-suppressing medications. Proton pump inhibitors (PPIs like omeprazole, esomeprazole) and H2 blockers (ranitidine, famotidine) directly suppress parietal cell function. These are among the most prescribed medications globally, often used long-term for GERD, even though the underlying cause in many patients is not excess acid but rather acid reaching the wrong place due to a dysfunctional lower esophageal sphincter, gut dysmotility, or insufficient acid for normal gastric emptying.

Chronic stress and zinc deficiency. Parietal cells require zinc as a cofactor for carbonic anhydrase, the enzyme central to HCl production. Zinc deficiency — common in vegetarians and in anyone eating a heavily processed diet — can directly impair acid output. Chronic psychological stress activates the HPA axis in ways that reduce gastric motility and, over time, parietal cell function.

The Acid Reflux Paradox

This is one of the most clinically consequential misunderstandings in digestive health. When the stomach is insufficiently acidic, the pyloric sphincter — which controls the passage of food into the small intestine — may delay gastric emptying. Food sits in the stomach longer, ferments, and produces gas. The pressure from this gas can push stomach contents (whatever acid is present) backward into the esophagus, causing the burning sensation interpreted as "too much acid."

The result: a patient with low acid gets prescribed an acid-suppressing drug, which reduces reflux symptoms in the short term by lowering the acidity of whatever comes back up — but further suppresses the root cause. Over time, digestion worsens, nutrient deficiencies compound, and the small intestine becomes more vulnerable to dysbiosis.

Not every case of GERD is caused by hypochlorhydria — genuine overacidity exists — but the distinction matters enormously for long-term management.

Betaine HCl: How It Works

Betaine hydrochloride is a compound in which betaine (a methyl donor derived from beets — see our Betaine page for context on betaine's other roles) is bound to a hydrochloric acid molecule. When swallowed, it dissociates in the stomach, releasing HCl and lowering gastric pH.

A controlled pharmacokinetic study in healthy volunteers showed that a single dose of betaine HCl (1,500 mg) lowered gastric pH from approximately 5.0 to 0.6 within 30 minutes — a drop of 4.5 pH units — and maintained pH below 3 for roughly 73 minutes before acid returned to pre-dose levels [1]. This temporary re-acidification was sufficient to restore the absorption of a pH-sensitive medication (dasatinib) by 15-fold, demonstrating that the acid produced is functionally relevant.

Dosing in practice. In integrative medicine, betaine HCl is typically taken with protein-containing meals. A common starting protocol: one capsule (500–750 mg) at the beginning of a meal, increasing by one capsule per meal every few days until a sensation of warmth or mild discomfort is felt in the stomach, then reducing by one capsule — this threshold is taken as an indicator that sufficient acid has been restored [2]. Doses as high as 3,000–5,000 mg per meal are sometimes used in functional medicine for people with significant hypochlorhydria, though evidence for specific dose targets is limited.

Betaine HCl should not be used by people taking NSAIDs, corticosteroids, or those with active gastric ulcers, as the combination can damage the gastric lining.

Supporting Stomach Acid Production Naturally

Zinc supplementation. Since zinc is essential for HCl synthesis, correcting deficiency — common in older adults and vegetarians — is a logical first step. Zinc-rich foods include oysters, red meat, pumpkin seeds, and fermented dairy. See our Zinc page for guidance on forms and dosing.

Digestive bitters. Bitter herbs (gentian, wormwood, artichoke, dandelion root) stimulate gastric acid secretion via activation of bitter taste receptors (TAS2Rs) in the gastric mucosa. See our Digestive Bitters page for detail on how bitters work and how to use them.

Apple cider vinegar. A tablespoon of raw apple cider vinegar in a small amount of water before protein-containing meals is widely used to compensate for low acid. Evidence is largely anecdotal, but the acetic acid content can modestly lower gastric pH and slow carbohydrate digestion. See our Apple Cider Vinegar page for what the studies show.

Manage H. pylori. If chronic atrophic gastritis is suspected, testing for H. pylori (breath test, stool antigen test, or endoscopy) and treating if positive can remove the primary cause of impaired acid secretion. Eradication typically involves antibiotic-based triple therapy, but certain natural compounds including mastic gum and zinc-carnosine have documented anti-H. pylori activity. See our Mastic Gum page and Zinc-Carnosine page for more.

Slow down at meals. Thorough chewing and relaxed eating (parasympathetic state) stimulates cephalic-phase acid secretion — the pre-digestive acid release triggered by seeing, smelling, and tasting food. Eating under stress, rushing, or engaging in conflict during meals blunts this phase meaningfully.

Evidence Review

Betaine HCl Pharmacokinetics

The most rigorous human study of betaine HCl (PMID 23980906) was a crossover pharmacokinetic trial in six healthy volunteers, performed at UCSF and published in Molecular Pharmaceutics [1]. The investigators induced hypochlorhydria using rabeprazole (a proton pump inhibitor) for five days, then tested whether betaine HCl could restore gastric acidity. A single dose of 1,500 mg betaine HCl reduced mean gastric pH from 5.2 to 0.6 within 30 minutes. Mean time to pH below 3 was 6.3 minutes; pH remained below 3 for a mean of 73 minutes and below 4 for 77 minutes. The re-acidification was sufficient to restore absorption of the poorly soluble drug dasatinib by 15-fold (Cmax) and 6.7-fold (AUC), demonstrating functional acid restoration relevant to nutrient absorption. All six subjects tolerated the intervention without adverse effects.

The 2020 narrative review by Guilliams and Drake (PMID 32549862) synthesizes the broader evidence for betaine HCl in functional hypochlorhydria [2]. The reviewers note that age-related delays in gastric re-acidification are well-documented — elderly individuals may require over four hours to restore normal pH after a meal-related acid secretion stimulus, versus rapid recovery in younger individuals — and that this creates a clinically meaningful window of inadequate digestion. The authors acknowledge that while definitive randomized trials of betaine HCl for hypochlorhydria outcomes (as opposed to pharmacokinetic endpoints) are limited, the mechanism of action is well-characterized and the risk profile at normal doses is low. They position betaine HCl supplementation as a reasonable evidence-informed intervention for functional hypochlorhydria, particularly in older adults and in those with documented acid suppression.

Hypochlorhydria and Iron Deficiency

The American Journal of Clinical Nutrition paper by Betesh et al. (PMID 25994564) provides the most compelling quantitative analysis of achlorhydria and iron deficiency anemia [4]. Reviewing available literature and mechanistic data, the authors documented that achlorhydria (complete absence of acid) was present in 44% of patients with idiopathic iron deficiency anemia, versus approximately 1.8% in controls — a roughly 24-fold enrichment. Achlorhydric patients demonstrated severe malabsorption of non-heme iron (the dominant form in plant-based and mixed diets), with iron absorption falling below the daily physiologic loss threshold, explaining the cumulative development of anemia. Dietary iron from fortified foods and supplements bound to ferric form was particularly poorly absorbed in the absence of acid. The authors concluded that gastritis-induced achlorhydria is an independent, underdiagnosed cause of iron deficiency anemia and should be considered in refractory cases that do not respond to iron supplementation alone.

A complementary pediatric study (PMID 23268321) involving 105 children in Chile found that H. pylori-infected children with elevated gastric pH (above 4.0) had significantly lower serum iron and transferrin saturation than both uninfected children and infected children with normal acid output [6]. Critically, uninfected children with isolated hypochlorhydria showed no iron abnormalities — pointing specifically to the combination of H. pylori infection and secondary hypochlorhydria as the driver of iron impairment, rather than hypochlorhydria alone.

Nutrient Absorption Mechanisms

The comprehensive 1989 review by Kassarjian and Russell from the USDA Human Nutrition Research Center on Aging at Tufts University (PMID 2669874) remains a key reference for the nutrition-hypochlorhydria relationship [3]. The review documents impaired absorption of non-heme iron, calcium, zinc, folic acid, and vitamin B12 in hypochlorhydric individuals, driven by three converging mechanisms: (1) reduced proteolytic activation of pepsin, impairing protein-bound nutrient liberation; (2) loss of the acidic environment needed for mineral ionization and solubilization; and (3) increased bacterial overgrowth in the small intestine, with bacteria competing for or metabolizing nutrients before absorption. The authors estimated that hypochlorhydria affects between 20–30% of community-dwelling older adults, making it a nutritionally significant but often unaddressed contributor to micronutrient deficiencies in aging populations.

Hypochlorhydria and Small Intestinal Dysbiosis

The 2022 preliminary observational study by Filardo et al. (PMID 35521214) used culture and molecular techniques to characterize duodenal microbiota in patients with chronic atrophic gastritis (hypochlorhydria) versus controls [5]. Hypochlorhydric patients showed significantly higher overall duodenal microbiota biodiversity — a finding that sounds positive but is not, as normal healthy duodenal microbiota are sparse by design. Specifically, patients with elevated gastric pH had increased colonization by oral-origin pathogens including Rothia mucilaginosa, Streptococcus salivarius, and Granulicatella adiacens — organisms that do not normally persist past the stomach's acid barrier. The authors proposed that hypochlorhydria disrupts a critical gatekeeping function of gastric acid, allowing oral and environmental bacteria to colonize the proximal small intestine, potentially contributing to pathology including duodenal ulceration, malabsorption, and systemic immune activation. This study was preliminary (small sample, observational design), but the mechanistic logic is robust and consistent with the broader SIBO literature.

Evidence Grading

Betaine HCl for temporary gastric re-acidification: moderate (controlled pharmacokinetic evidence, well-characterized mechanism, limited outcome trial data). Hypochlorhydria as a cause of iron deficiency: moderate to strong (cross-sectional data, clear mechanistic pathway, H. pylori-mediated cases particularly well-documented). Hypochlorhydria and B12 deficiency: moderate (epidemiological evidence from PPI users, mechanistic clarity, gastric bypass data confirming food-bound B12 sensitivity to acid). Hypochlorhydria and gut dysbiosis: preliminary (single observational study, mechanistically plausible, consistent with larger SIBO literature). The overall evidence supports routine consideration of low stomach acid in patients with unexplained nutrient deficiencies, refractory anemia, chronic digestive symptoms, or long-term PPI use — even though large-scale intervention trials with betaine HCl remain lacking.

References

  1. Gastric reacidification with betaine HCl in healthy volunteers with rabeprazole-induced hypochlorhydriaYago MR, Frymoyer AR, Smelick GS, Frassetto LA, Budha NR, Dresser MJ, Ware JA, Benet LZ. Molecular Pharmaceutics, 2013. PubMed 23980906 →
  2. Meal-Time Supplementation with Betaine HCl for Functional Hypochlorhydria: What is the Evidence?Guilliams TG, Drake LE. Integrative Medicine (Encinitas), 2020. PubMed 32549862 →
  3. Hypochlorhydria: a factor in nutritionKassarjian Z, Russell RM. Annual Review of Nutrition, 1989. PubMed 2669874 →
  4. Is achlorhydria a cause of iron deficiency anemia?Betesh AL, Santa Ana CA, Cole JA, Fordtran JS. American Journal of Clinical Nutrition, 2015. PubMed 25994564 →
  5. The Potential Role of Hypochlorhydria in the Development of Duodenal Dysbiosis: A Preliminary ReportFilardo S, Scalese G, Virili C, Pontone S, Di Pietro M, Covelli A, Bedetti G, Marinelli P, Bruno G, Stramazzo I, Centanni M, Sessa R, Severi C. Frontiers in Cellular and Infection Microbiology, 2022. PubMed 35521214 →
  6. Helicobacter pylori-associated hypochlorhydria in children, and development of iron deficiencyHarris PR, Serrano CA, Villagrán A, Walker MM, Thomson M, Duarte I, Windle HJ, Crabtree JE. Journal of Clinical Pathology, 2013. PubMed 23268321 →

Weekly Research Digest

Get new topics and updated research delivered to your inbox.